Hepatitis B virus promotes hepatocellular carcinogenesis by activating IL-6-dependent tumor-macrophage crosstalk and M2-like macrophage polarization
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2026.113283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Yingqi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Chongqing University, Chongqing, P. R. China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Interleukin-6, Hepatitis B virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chongqing Municipal Science and Technology Bureau, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Hepatitis B virus X protein (HBx) is a prominent promoter of hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC) in the clinic, but the associated pro-tumorigenic mechanisms are still not well elucidated, especially its potential involvement in the tumor immunoevasion and immunotolerance. Surprisingly, we found that HBx expression status of HCC cells showed marked positive correlation with its interleukin 6 (IL-6) secretion, which drove M2 macrophage polarization via activating signal transducer and activator of transcription 3 (STAT3) signaling and fostered an immunosuppressive tumor microenvironment (TME). During this process, HBx partially translocated into mitochondria to cause mitochondrial DNA (mtDNA) leakage and activate absent in melanoma 2 (AIM2)-IL1β-nuclear factor kappa-B (NF-κB) signaling for boosting tumor-intrinsic IL-6 production. In line with these mechanistic insights, blocking IL-6 signaling in HBx-positive HCC tumors significantly revitalized the antitumor immune responses and retarded tumor growth, which also showed good synergy with programmed cell death protein 1 (PD-1) antibody therapy. Overall, this study revealed a non-canonical role of HBx in driving HCC progression while offering potential anti-HCC immunotherapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science, Chongqing University, Chongqing, P. R. China.
- Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, P. R. China.
- School of Life Science, Chongqing University, Chongqing, P. R. China. Electronic address: menghuanli@cqu.edu.cn.
- School of Life Science, Chongqing University, Chongqing, P. R. China. Electronic address: luozhong918@cqu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Chongqing Municipal Science and Technology Bureau
- China Postdoctoral Science Foundation
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Liu, Y., Cao, X., Yang, B., Zheng, H., Zhong, H., Tao, D., Li, M., & Luo, Z. (2026). Hepatitis B virus promotes hepatocellular carcinogenesis by activating IL-6-dependent tumor-macrophage crosstalk and M2-like macrophage polarization. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113283
Vancouver
Liu Y, Cao X, Yang B, Zheng H, Zhong H, Tao D, et al. Hepatitis B virus promotes hepatocellular carcinogenesis by activating IL-6-dependent tumor-macrophage crosstalk and M2-like macrophage polarization. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.113283
BibTeX
@article{Liu2026,
author = {Liu, Yingqi and Cao, Xinyi and Yang, Bingbing and Zheng, Hongmei and Zhong, Hongyu and Tao, Dan and Li, Menghuan and Luo, Zhong},
title = {Hepatitis B virus promotes hepatocellular carcinogenesis by activating IL-6-dependent tumor-macrophage crosstalk and M2-like macrophage polarization},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2026.113283}
}
EUVIMED